

( (S (NP-SBJ Bio-Technology General Corp.)
     (VP received
         (NP (NP tenders)
	     (PP for
		 (NP (NP (NP 97.9 %)
			 (PP of
			     (NP (NP its 
				     (ADJP 7.5 %) 
				     convertible senior subordinated notes)
				 (ADJP due
				       (NP-TMP (NP April 15)
					       , 
					       (NP 1997))))))
		     , 
		     and
		     (NP (NP 96 %)
			 (PP of
			     (NP (NP its 
				     (ADJP 11 %) 
				     convertible senior subordinated debentures)
				 (ADJP due
				       (NP-TMP (NP March 1) 
					       , 
					       (NP 2006))))))))))
     .))
( (S (PP-LOC In
	     (NP (NP exchange offers)
		 (SBAR (WHNP-1 that)
		       (S (NP-SBJ *T*-1)
			  (VP expired
			      (NP-TMP Friday))))))
     ,
     (NP-SBJ (NP holders)
             (PP of
                 (NP (NP each 
			 $ 1,000 *U*)
                     (PP of
                         (NP notes)))))
     (VP will
         (VP receive
             (NP (NP (NP (ADJP $ 250 *U*)
			 face amount)
                     (PP of
                         (NP (NP Series A 
				 (ADJP 7.5 %) 
				 senior secured convertible notes)
                             (ADJP due
                                   (NP-TMP (NP Jan. 15)
					   , 
					   (NP 1995))))))
                 , 
		 and
                 (NP 200 common shares))))
     .))
( (S (PP For
         (NP (NP each 
		 (ADJP $ 1,000 *U*)
		 face amount)
             (PP of
                 (NP debentures))))
     ,
     (NP-SBJ holders)
     (VP received
         (NP (NP (NP $ 250 *U*)
                 (PP of
                     (NP (NP Series B 
			     (ADJP 11 %) 
			     senior secured convertible notes)
                         (ADJP due
                               (NP-TMP (NP Oct. 15) 
				       , 
				       (NP 1998))))))
             , 
	     and
             (NP 200 common shares)))
     .))
( (S (NP-SBJ (NP Bio-Technology)
             ,
             (NP (NP a New York maker)
                 (PP of
                     (NP (NP (ADJP genetically
				   engineered)
			     products)
                         (PP for
                             (NP (UCP human and animal) health care)))))
	     ,)
     (VP said
         (SBAR 0
               (S (NP-SBJ-1 it)
                  (VP made
                      (NP the exchange offer)
		      (S-PRP (NP-SBJ *-1)
			     (VP to
				 (VP reduce
				     (NP its interest payments))))))))
     .))
